Given CDC recommended dosing for GARDASIL 9 differs from the FDA-approved recommended dosing, any cost or coverage information may be out of date. As always, please contact your insurance provider for specific information about your costs or coverage.<\/strong><\/p>\n<\/div><\/div><\/div>\n\n\n\n Figuring out what you might pay out-of-pocket for a vaccination can be confusing. What you pay will depend on many factors, including your insurance situation and if there are financial support options available to you. At Merck, we believe that you should be better able to understand what you can expect to pay out of your own pocket for your shot.<\/strong><\/p>\n\n\n\n The list price for each indicated dose of GARDASIL 9 is $328.34.a<\/sup> Most people will not pay the list price, although it may have an impact on your out-of-pocket costs.b<\/sup> The amount you pay will depend on many factors, including your insurance situation. The information below will help you better estimate what you may pay for your vaccination based on your insurance situation.c <\/sup>For the actual out-of-pocket cost of your vaccine, talk to your insurance provider, who knows the details of your plan if you have insurance, or contact your health care provider\u2019s office for help.<\/p>\n\n\n\n GARDASIL 9 is a shot that is usually given in the arm muscle. GARDASIL 9 may be given as 2 or 3 shots.<\/p>\n\n\n\n\n The appropriate dosing schedule will be determined by your health care professional.<\/p>\n\n\n\n a<\/sup>The list price is current as of August 2025. The list price does not include vaccine administration fees.<\/p>\n\n\n\n b<\/sup>The out-of-pocket costs include the price patients paid for GARDASIL 9.<\/span><\/p>\n\n\n\n c<\/sup>The out-of-pocket costs below do not include costs associated with administration of GARDASIL 9.<\/span><\/p>\n\n\n\n Vaccination in doctor\u2019s office<\/strong><\/p>\n\n\n\n I have commercial insurance through an employer or private policy that covers GARDASIL 9.<\/span><\/strong><\/p>\n\n\n\n For patients with commercial insurance, 99% of patients paid no out-of-pocket costs for a shot of GARDASIL 9. For those patients who did have out-of-pocket costs, 80% of patients paid between $0.01 and $365 for a shot of GARDASIL 9.\u00b9<\/sup><\/p>\n\n\n\n \u00b9<\/sup>IQVIA GARDASIL 9<\/em> OOP Costs, August 2025. Based on an analysis of September 2024 to August 2025 commercial, Medicare, and IQVIA Medicaid claims. Commissioned by Merck Sharp & Dohme LLC. IQVIA\u2019s analysis is based on remittance data that provide claim payment information after medical claims have been processed by the patient\u2019s medical insurer and assigned to primary payer channel. The data are limited to remittance transactions on medical claims collected by IQVIA and may not constitute a nationally representative sample. Please note that a patient\u2019s cost may differ from the amounts depicted above.<\/p>\n<\/div>\n\n\n\n Vaccination in pharmacy<\/strong><\/p>\n\n\n\n I have commercial insurance through an employer or private policy that covers GARDASIL 9.<\/span><\/strong><\/p>\n\n\n\n For patients with commercial insurance, 98.7% of patients paid no out-of-pocket costs for a shot of GARDASIL 9. For those patients who did have out-of-pocket costs, 80% of patients paid between $0.98 and $311 for a shot of GARDASIL 9.\u00b9<\/sup><\/p>\n\n\n\n \u00b9IQVIA\u2122: OPC Provider for the period September 2024 to August 2025 reflecting real-world claims activity for administration from retail pharmacies for which data are available in the IQVIA\u2122: OPC Provider database. Reported ranges are based on actual final patient out-of-pocket costs (for commercially insured patients) for patients vaccinated with GARDASIL 9. Reported ranges include both paid and reversed claims for vaccinations for which data are available. All out-of-pocket cost values are based on a single shot of GARDASIL 9. Data accessed as of August 2025. All rights reserved.<\/p>\n<\/div>\n<\/div>\n<\/div><\/details><\/div>\n\n\n\n Vaccination in doctor\u2019s office<\/strong><\/p>\n\n\n\n I have coverage for GARDASIL 9 through Medicare<\/strong>.<\/p>\n\n\n\n For patients with Medicare coverage, 98.5% of patients paid no out-of-pocket costs for a shot of GARDASIL 9. For those patients who did have out-of-pocket costs, 80% of patients paid between $0.01 and $375 for a shot of GARDASIL 9.\u00b9<\/p>\n\n\n\n \u00b9IQVIA GARDASIL 9<\/em> OOP Costs, August 2025. Based on an analysis of September 2024 to August 2025 commercial, Medicare, and Medicaid claims. Commissioned by Merck Sharp & Dohme LLC. IQVIA\u2019s analysis is based on remittance data that provide claim payment information after medical claims have been processed by the patient\u2019s medical insurer and assigned to primary payer channel. The data are limited to remittance transactions on medical claims collected by IQVIA and may not constitute a nationally representative sample. Please note that a patient\u2019s cost may differ from the amounts depicted above.<\/p>\n<\/div>\n\n\n\n Vaccination in pharmacy<\/strong><\/p>\n\n\n\n I have coverage for GARDASIL 9 through Medicare.<\/strong><\/p>\n\n\n\n For patients with Medicare Part D coverage, 97.05% of patients paid no out-of-pocket costs for a shot of GARDASIL 9. For those patients who did have out-of-pocket costs, 80% of patients paid between $1 and $302 for a shot of GARDASIL 9.\u00b9<\/sup><\/p>\n\n\n\n \u00b9IQVIA\u2122: OPC Provider for the period September 2024 to August 2025 reflecting real-world claims activity for administration from retail pharmacies for which data are available in the IQVIA\u2122: OPC Provider database. Reported ranges are based on actual final patient out-of-pocket costs for patients vaccinated with GARDASIL 9. Reported ranges include both paid and reversed claims for vaccinations for which data are available. All out-of-pocket cost values are based on a single shot of GARDASIL 9. For Medicare, low income subsidy patients are included in out-of-pocket cost calculations. Data accessed as of August 2025. All rights reserved. Please note that a patient\u2019s cost may differ from the amounts depicted above.<\/p>\n<\/div>\n<\/div>\n<\/div><\/details><\/div>\n\n\n\n Vaccination in doctor\u2019s office<\/strong><\/p>\n\n\n\n I have coverage for GARDASIL 9 through Medicaid.<\/strong><\/p>\n\n\n\n For patients with Medicaid, 99.7% of patients paid no out-of-pocket costs for a shot of GARDASIL 9.\u00b9 For those patients who did have out-of-pocket costs, 80% of patients paid between $0.01 and $350. To learn more about Medicaid in your state and find out if you\u2019re eligible, visit https:\/\/www.medicaid.gov\/medicaid-and-you\/index.html<\/span><\/a><\/p>\n\n\n\n \u00b9IQVIA GARDASIL 9<\/em> OOP Costs, August 2025. Based on an analysis of September 2024 to August 2025 commercial, Medicare, and Medicaid claims. Commissioned by Merck Sharp & Dohme LLC. IQVIA\u2019s analysis is based on remittance data that provide claim payment information after medical claims have been processed by the patient\u2019s medical insurer and assigned to primary payer channel. The data are limited to remittance transactions on medical claims collected by IQVIA and may not constitute a nationally representative sample. Please note that a patient\u2019s cost may differ from the amounts depicted above.<\/p>\n<\/div>\n\n\n\nCost Information<\/h1><\/div>\n\n\n\n
Choose an option below that best describes your insurance situation:<\/strong><\/h2><\/div>\n<\/div><\/div><\/div>\n\n\n\n
Commercial or private insurance<\/h4><\/summary>
Medicare<\/h4><\/summary>
Medicaid<\/h4><\/summary>